Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019

Background: Coronavirus disease 2019 (COVID-19) is a novel disease associated with a cytokine-mediated, severe, acute respiratory syndrome. Tocilizumab and lenzilumab are recombinant monoclonal antibodies against IL-6 and granulocyte macrophage colony-stimulating factor, respectively, and have been...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Immunotherapy
Main Authors: Melody, Megan, Nelson, Jared, Hastings, Jacquelyn, Propst, Joshua, Smerina, Michael, Mendez, Julio, Guru, Pramod
Format: Artigo
Sprog:Inglês
Udgivet: Future Medicine Ltd 2020
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7319491/
https://ncbi.nlm.nih.gov/pubmed/32546029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2020-0136
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker